HORIZON
PharmEco
Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 34,367,099
- EU contribution
- EUR 16,035,533
- Participants
- 26 from 10 countries
- Topic
- HORIZON_HORIZON-JU-IHI-2023-04-06-two-stage
- Grant agreement
- 101165889
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Vtu Engineering Belgium BV | BEBelgium | Participant | EUR 289,519 | PIC (1.00) |
| Ares Trading SA | CHSwitzerland | Associated partner | EUR 0 | PIC (1.00) |
| UCB Farchim | CHSwitzerland | Associated partner | EUR 0 | PIC (1.00) |
| Merck Electronics Kgaa | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Deutschland GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| UCB BioSciences GmbH | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Aimplas - Asociacion de Investigacion de Materiales Plasticos y Conexas | ESSpain | Participant | EUR 260,760 | PIC (1.00) |
| Cultzyme SL | ESSpain | Participant | EUR 413,438 | PIC (1.00) |
| Benkei | FRFrance | Participant | EUR 423,700 | PIC (1.00) |
| Oril Industrie | FRFrance | Associated partner | EUR 0 | PIC (1.00) |
| Sfe Process | FRFrance | Participant | EUR 494,862 | PIC (1.00) |
| Sofradim Production Sasu | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Astrazeneca UK Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Biotoolomics Limited | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Loughborough University | GBUnited Kingdom | Associated partner | EUR 0 | known name (0.95) |
| UCB celltech pharmaceuticals | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Pfizer Healthcare India Private Limited | INIndia | Associated partner | EUR 0 | PIC (1.00) |
| Merck Serono SpA | ITItaly | Associated partner | EUR 0 | PIC (1.00) |
| Pfizer Italia s.r.l. | ITItaly | Associated partner | EUR 0 | PIC (1.00) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 579,959 | known name (0.95) |
| Ucb Pharma B.V. | NLNetherlands | Associated partner | EUR 0 | PIC (1.00) |
| AstraZeneca Pharmaceuticals LP | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Sanofi Genzyme | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Sanofi US Services Inc. | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 26 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.